1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Pennsylvania >
  6. Precision Therapeutics Acquires Helomics

M&A Deal Summary

Precision Therapeutics Acquires Helomics

On June 28, 2018, Precision Therapeutics acquired life science company Helomics

Acquisition Highlights
  • This is Precision Therapeutics’ 1st transaction in the Life Science sector.
  • This is Precision Therapeutics’ 1st transaction in the United States.
  • This is Precision Therapeutics’ 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2018-06-28
Target Helomics
Sector Life Science
Buyer(s) Precision Therapeutics
Deal Type Add-on Acquisition

Target

Helomics

Pittsburgh, Pennsylvania, United States
Helomics Corp. is a precision medicine company and integrated clinical contract research organization whose mission is to improve patient care by partnering with pharmaceutical, diagnostic, and academic organizations to bring innovative clinical products and technologies to the marketplace. Helomics was founded in 1995 and is based in Pittsburgh, Pennsylvania.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Precision Therapeutics

Pittsburgh, Pennsylvania, United States
Category Company
Sector Life Science
DESCRIPTION

Precision Therapeutics, Inc. provides personalized cancer management services. The company offers personalized cancer management information and customized pre-clinical drug testing services to the medical and biopharmaceutical community. Its ChemoFx assay assists physicians in evaluating optimal therapy options for individual patients. Precision Therapeutics is based in Pittsburgh, Pennsylvania.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Pennsylvania M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2018 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal